Overview

Behavioral and Subjective Efficacy of Ramelteon in Subjects With a History of Polydrug Abuse

Status:
Completed
Trial end date:
2003-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the relative abuse potential of ramelteon, once daily (QD), compared to triazolam in subjects with a history of drug abuse.
Phase:
Phase 2
Details
Lead Sponsor:
Takeda
Treatments:
Triazolam